Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Expands Drug Discovery Facilities in Missouri

NEW YORK (GenomeWeb News) – Millipore said today that it will spend $3.4 million to expand its drug discovery business unit’s operations in St. Charles, Mo.
 
The Billerica, Mass.-based firm also said that it plans to hire an additional 60 employees at the St. Charles site. Millipore gained the site through its $1.4 billion acquisition of Serologicals in 2006.
 
The firm said that it is seeking LEED certification of the expanded and renovated 17,000-square-foot space. Millipore noted that the expanded facility is one of three buildings on the firm’s 43-acre Missouri Research Park campus.
 
“Our expanded St. Charles facility will help us meet the needs of customers at every stage of the drug discovery and development pipeline — from target identification through clinical studies,” Rick Ryan, vice president of Millipore’s drug discovery and development business unit, said in a statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.